Literature DB >> 9358550

The stability of insulin in crystalline and amorphous solids: observation of greater stability for the amorphous form.

M J Pikal1, D R Rigsbee.   

Abstract

PURPOSE: Generalizations based upon behavior of small molecules have established that a crystalline solid is generally much more stable toward chemical degradation than is the amorphous solid. This study examines the validity of this generalization for proteins using biosynthetic human insulin as the model protein.
METHODS: Amorphous insulin was prepared by freeze drying the supernate from a suspension of zinc insulin crystals adjusted to pH 7.1. Storage stability at 25 degrees C and 40 degrees C were compared for the freeze dried material, the dried suspended crystals, and the starting batch of crystals. Samples were equilibrated at selected relative humidities between zero and 75% to obtain samples at various water contents. Assays for dimer formation were performed by size exclusion HPLC and assays for deamidated product were carried out by reverse phase HPLC. Degradation was found to be linear in square root of time, and the slopes from % degradation vs. square root of time were used to define the rate constants for degradation. Differential scanning calorimetry (DSC) and Fourier-transform infrared spectroscopy (FTIR) were used to characterize the state of the protein in the solids.
RESULTS: As expected based upon previous results, the primary degradation pathways involve deamidation at the AsnA21 site and co-valent dimer formation, presumably involving the A-21 site. Contrary to expectations, amorphous insulin is far more stable than crystalline insulin under all conditions investigated. While increasing water content increases the rate of degradation of crystalline insulin, rate constants for degradation in the amorphous solid are essentially independent of water content up to the maximum water content studied (approximately 15%).
CONCLUSIONS: Based upon the FTIR and DSC data, both crystalline and amorphous insulin retain some higher order structure when dried, but the secondary structure is significantly perturbed from that characteristic of the native solution state. However, neither DSC nor FTIR data provide a clear interpretation of the difference in stability between the amorphous and crystalline solids. The mechanism responsible for the superior stability of amorphous insulin remains obscure.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9358550     DOI: 10.1023/a:1012164520429

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  19 in total

1.  Influence of transition rates and scan rate on kinetic simulations of differential scanning calorimetry profiles of reversible and irreversible protein denaturation.

Authors:  J R Lepock; K P Ritchie; M C Kolios; A M Rodahl; K A Heinz; J Kruuv
Journal:  Biochemistry       Date:  1992-12-22       Impact factor: 3.162

2.  Fourier-transform infrared spectroscopic investigation of protein stability in the lyophilized form.

Authors:  H R Costantino; K Griebenow; P Mishra; R Langer; A M Klibanov
Journal:  Biochim Biophys Acta       Date:  1995-11-15

Review 3.  Protein liquid chromatographic analysis in biotechnology.

Authors:  L J Janis; P M Kovach; R M Riggin; J K Towns
Journal:  Methods Enzymol       Date:  1996       Impact factor: 1.600

4.  Solid-state stability of human insulin. I. Mechanism and the effect of water on the kinetics of degradation in lyophiles from pH 2-5 solutions.

Authors:  R G Strickley; B D Anderson
Journal:  Pharm Res       Date:  1996-08       Impact factor: 4.200

5.  Evidence for a common intermediate in insulin deamidation and covalent dimer formation: effects of pH and aniline trapping in dilute acidic solutions.

Authors:  R T Darrington; B D Anderson
Journal:  J Pharm Sci       Date:  1995-03       Impact factor: 3.534

6.  Secondary structure of the pentraxin female protein in water determined by infrared spectroscopy: effects of calcium and phosphorylcholine.

Authors:  A Dong; B Caughey; W S Caughey; K S Bhat; J E Coe
Journal:  Biochemistry       Date:  1992-10-06       Impact factor: 3.162

7.  Chemical stability of insulin. 1. Hydrolytic degradation during storage of pharmaceutical preparations.

Authors:  J Brange; L Langkjaer; S Havelund; A Vølund
Journal:  Pharm Res       Date:  1992-06       Impact factor: 4.200

8.  The effects of formulation variables on the stability of freeze-dried human growth hormone.

Authors:  M J Pikal; K M Dellerman; M L Roy; R M Riggin
Journal:  Pharm Res       Date:  1991-04       Impact factor: 4.200

9.  Molecular mobility of amorphous pharmaceutical solids below their glass transition temperatures.

Authors:  B C Hancock; S L Shamblin; G Zografi
Journal:  Pharm Res       Date:  1995-06       Impact factor: 4.200

10.  Separation of freezing- and drying-induced denaturation of lyophilized proteins using stress-specific stabilization. II. Structural studies using infrared spectroscopy.

Authors:  S J Prestrelski; T Arakawa; J F Carpenter
Journal:  Arch Biochem Biophys       Date:  1993-06       Impact factor: 4.013

View more
  14 in total

1.  Usefulness of the Kohlrausch-Williams-Watts stretched exponential function to describe protein aggregation in lyophilized formulations and the temperature dependence near the glass transition temperature.

Authors:  S Yoshioka; Y Aso; S Kojima
Journal:  Pharm Res       Date:  2001-03       Impact factor: 4.200

Review 2.  Diamonds in the rough: protein crystals from a formulation perspective.

Authors:  A Jen; H P Merkle
Journal:  Pharm Res       Date:  2001-11       Impact factor: 4.200

3.  Fast dynamics and stabilization of proteins: binary glasses of trehalose and glycerol.

Authors:  Marcus T Cicerone; Christopher L Soles
Journal:  Biophys J       Date:  2004-06       Impact factor: 4.033

4.  Drying-induced variations in physico-chemical properties of amorphous pharmaceuticals and their impact on Stability II: stability of a vaccine.

Authors:  Ahmad M Abdul-Fattah; Vu Truong-Le; Luisa Yee; Emilie Pan; Yi Ao; Devendra S Kalonia; Michael J Pikal
Journal:  Pharm Res       Date:  2007-02-15       Impact factor: 4.200

5.  Photolysis of recombinant human insulin in the solid state: formation of a dithiohemiacetal product at the C-terminal disulfide bond.

Authors:  Olivier Mozziconacci; Jessica Haywood; Eric M Gorman; Eric Munson; Christian Schöneich
Journal:  Pharm Res       Date:  2011-07-12       Impact factor: 4.200

6.  Effect of sucrose/raffinose mass ratios on the stability of co-lyophilized protein during storage above the Tg.

Authors:  P Davidson; W Q Sun
Journal:  Pharm Res       Date:  2001-04       Impact factor: 4.200

7.  A quantitative assessment of the significance of molecular mobility as a determinant for the stability of lyophilized insulin formulations.

Authors:  Sumie Yoshioka; Yukio Aso
Journal:  Pharm Res       Date:  2005-08-03       Impact factor: 4.200

8.  Effect of the Freezing Step in the Stability and Bioactivity of Protein-Loaded PLGA Nanoparticles Upon Lyophilization.

Authors:  Pedro Fonte; Fernanda Andrade; Cláudia Azevedo; João Pinto; Vítor Seabra; Marco van de Weert; Salette Reis; Bruno Sarmento
Journal:  Pharm Res       Date:  2016-07-21       Impact factor: 4.200

9.  Influence of stabilizers on the physicochemical characteristics of inhaled insulin powders produced by supercritical antisolvent process.

Authors:  Yong Ho Kim; Constantinos Sioutas; Katherine S Shing
Journal:  Pharm Res       Date:  2008-09-04       Impact factor: 4.200

10.  Biologic comparison of inhaled insulin formulations: Exubera™ and novel spray-dried engineered particles of dextran-10.

Authors:  Philip J Kuehl; Alan Cherrington; Dan E Dobry; Dale Edgerton; Dwayne T Friesen; Charles Hobbs; Chet L Leach; Brice Murri; Doss Neal; David K Lyon; David T Vodak; Matthew D Reed
Journal:  AAPS PharmSciTech       Date:  2014-08-09       Impact factor: 3.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.